ArticleBMC infectious diseases2026
Prevalence of chronic viral hepatitis B, D among Mongol migrants in Sweden compared to a sex- and age-matched native Mongol cohort.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
aimsChronic hepatitis B/D is the most severe form of chronic viral hepatitis, yet public awareness of its burden remains low. This study examined the prevalence of viral hepatitis B and D among Mongol migrants in Sweden and facilitated linkage to care.
methodsWe conducted a viral hepatitis screening event on January 28th -29th, 2023 at Karolinska University Hospital, Stockholm, for individuals of Mongol descent. Consenting participants underwent blood testing and liver stiffness measurements. The prevalence of viral hepatitis was compared with an age- and sex-matched general population cohort in Mongolia.
resultsWe screened 850 adult Mongols (mean age (SD) 43.2 ± 8.6 years; 61.9% women). The prevalence of HBsAg+, anti-HDV+, and HDV-RNA + were 4.4%, 2.1%, and 1.3%, respectively. The corresponding prevalences in the matched native Mongol cohort were significantly higher at 9.8%, 5.1%, and 3.7%. Among HBsAg + individuals, 48.6% were anti-HDV+; 61.1% of anti-HDV + individuals had detectable HDV-RNA. Prior HBV infection was identified in 62.9% of participants, 8.7% had evidence of vaccination, and 22.8% were susceptible to HBV infection. Overall, 58 (6.8%) individuals with chronic viral hepatitis were linked to care. Among HBsAg + or anti-HBc + individuals, only 54.1% and 65.8% were aware of their current or past HBV infection, respectively. Anti-HCV + prevalence was 18.6%; 13.3% had detectable HCV-RNA, indicating chronic infection.
conclusionMongol migrants had lower prevalences of hepatitis B and D than the general population in Mongolia, but higher than in the Swedish general population. Increased screening efforts are needed to enhance awareness, improve diagnosis and linkage to care for populations at higher risk of chronic viral hepatitis in Sweden and Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.